MMSI logo

Merit Medical Systems, Inc. Stock Price

NasdaqGS:MMSI Community·US$3.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

MMSI Share Price Performance

US$64.17
64.17 (0.00%)
US$98.36
Fair Value
US$64.17
64.17 (0.00%)
34.8% undervalued intrinsic discount
US$98.36
Fair Value
Price US$64.17
AnalystConsensusTarget US$98.36
AnalystLowTarget US$74.00
AnalystHighTarget US$118.22

MMSI Community Narratives

·
Fair Value US$98.36 34.4% undervalued intrinsic discount

Global Aging And Healthcare Demand Will Expand Medical Procedures

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$74 12.8% undervalued intrinsic discount

Tariffs And OEM Volatility Will Pressure Margins Yet Long Term Procedure Demand Will Support Progress

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$118.22 45.4% undervalued intrinsic discount

Oncology And Endoscopy Platforms Will Reshape Long Term Earnings Power

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$118.22
45.4% undervalued intrinsic discount
Revenue
6.34% p.a.
Profit Margin
11.84%
Future PE
41.56x
Price in 2029
US$148.8
US$74
12.8% undervalued intrinsic discount
Revenue
5.86% p.a.
Profit Margin
11.48%
Future PE
27.13x
Price in 2029
US$93.8
US$98.36
34.4% undervalued intrinsic discount
Revenue
6.36% p.a.
Profit Margin
10.81%
Future PE
37.99x
Price in 2029
US$123.91

Trending Discussion

Updated Narratives

MMSI logo

Oncology And Endoscopy Platforms Will Reshape Long Term Earnings Power

Fair Value: US$118.22 45.4% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
MMSI logo

Tariffs And OEM Volatility Will Pressure Margins Yet Long Term Procedure Demand Will Support Progress

Fair Value: US$74 12.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
MMSI logo

MMSI: 2026 Guidance Execution And Margin Resilience Will Drive Future Upside

Fair Value: US$98.36 34.4% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and fair value.

0 Risks
3 Rewards

Merit Medical Systems, Inc. Key Details

US$1.5b

Revenue

US$791.4m

Cost of Revenue

US$751.0m

Gross Profit

US$611.7m

Other Expenses

US$139.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
2.34
48.69%
9.03%
45.2%
View Full Analysis

About MMSI

Founded
1987
Employees
7500
CEO
Martha Aronson
WebsiteView website
www.merit.com

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Recent MMSI News & Updates

New Narrative May 16

Oncology And Endoscopy Platforms Will Reshape Long Term Earnings Power

Catalysts About Merit Medical Systems Merit Medical Systems develops and sells medical devices used in vascular, oncology, cardiac, renal and endoscopy procedures worldwide. What are the underlying business or industry changes driving this perspective?

Recent updates

No updates